Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,233 | -14,418 | -9,969 | -5,410 | -15,509 |
| Depreciation Amortization | 35 | 28 | 17 | 8 | 27 |
| Accounts payable and accrued liabilities | -20 | -997 | -498 | -764 | 963 |
| Other Working Capital | 663 | -328 | 386 | 112 | 769 |
| Other Operating Activity | 1,541 | 2,331 | 2,023 | 2,259 | 808 |
| Operating Cash Flow | $-18,015 | $-13,384 | $-8,041 | $-3,795 | $-12,942 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19 | -32 | -3 | -35 | -8,980 |
| PPE Investments | -24 | -24 | -9 | -8 | -57 |
| Other Investing Activity | -2 | -1 | -1 | -1 | 296 |
| Investing Cash Flow | $-7 | $-57 | $-13 | $-43 | $-8,741 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37,160 | 37,095 | 36,178 | 36,065 | 28,564 |
| Financing Cash Flow | $37,160 | $37,095 | $36,178 | $36,065 | $28,564 |
| Beginning Cash Position | 9,097 | 9,097 | 9,097 | 9,097 | 2,216 |
| End Cash Position | 28,235 | 32,751 | 37,222 | 41,323 | 9,097 |
| Net Cash Flow | $19,138 | $23,654 | $28,125 | $32,227 | $6,881 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,015 | -13,384 | -8,041 | -3,795 | -12,942 |
| Capital Expenditure | -24 | -24 | -9 | -8 | -57 |
| Free Cash Flow | -18,039 | -13,407 | -8,050 | -3,803 | -12,999 |